2025 annual financial data
Nanobiotix 2025 Operating margin
Direct answer
Operating margin was -36.49%.
Operating income was -10,818,000 EUR and net income was -23,961,000 EUR.
Operating cash flow was -33,422,000 EUR.
Get free Nanobiotix email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 29,643,000 EUR
- Operating income
- -10,818,000 EUR
- Net income
- -23,961,000 EUR
- Operating cash flow
- -33,422,000 EUR